NanoString is the first company to achieve the scientific breakthrough of providing true single-cell whole transcriptome imaging. This technological milestone was accomplished using the CosMx SMI ...

NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the CosMx™ Human 6K ...

New liver tissue dataset highlights high sensitivity and specificity of CosMx system, and the biological power of spatially analyzing 1000 RNA targets NanoString Technologies, Inc. (NASDAQ: NSTG), a ...

NanoString Technologies. “The CosMx SMI is ideally suited to explore the ‘private lives’ of single cells, how they are organized into ‘neighborhoods’ within tissue, and how they ...

NanoString captured new orders for spatial biology instruments at a rate exceeding the Q1 pace and retained more than $30 million in the CosMx instrument order backlog. "During Q2, a competitor ...

That includes continuing to serve its customer base of researchers who use NanoString’s nCounter, GeoMx and CosMx platforms, which are used to spatially profile the RNA and certain protein ...

10x Genomics is seeking an injunction and other remedies against NanoString's GeoMx and CosMx products. NanoString CEO Brad Gray disagreed with the decision, adding that the firm "will continue to ...

Major milestone marked by first public dataset released for CosMx Whole Transcriptome Panel with additional data forthcoming at the AGBT Meeting NanoString is marking this milestone achievement ...

Wednesday, 10x Genomics Inc TXG won an injunction in its patent litigation against NanoString Technologies Inc NSTG and its German subsidiary regarding CosMx Spatial Molecular Imager instruments.